La Vista, NE – Streck, Inc. and Farmalatina Ltda., Santiago, Chile, have signed a distribution agreement for Streck’s full portfolio of quality control, cell stabilization, and molecular products. Streck’s portfolio includes quality control products that test the performance and limits of instruments and reagents, helping laboratories meet regulatory and accreditation requirements; sample collection devices for […]

Program could lead to new crop protection solutions for farmers worldwide Chengdu, China. HitGen Ltd announced that the company has entered into a research collaboration with the Crop Science division of Bayer to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded […]

InSphero and Path BioAnalytics Announce Partnership to Develop Advanced 3D Airway Tissue Model for Cystic Fibrosis Research Path BioAnalytics to explore InSphero 3D cell technology to produce organoids from primary Cystic Fibrosis patient tissues to aid the development of new treatments Schlieren, Switzerland — InSphero AG and Path BioAnalytics today announced a partnership through which […]

SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that health officials from the National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued a recommendation that includes the use of the Prosigna® Breast Cancer Gene Signature Assay result to guide adjuvant chemotherapy decisions for […]

Existing investors contribute an additional $30 million to accelerate tools that will revolutionize genomic research BOULDER, Colo. — Inscripta™, a leading gene-editing technology company, today announced that MAD7, its proprietary CRISPR enzyme, has achieved wide adoption by academic, commercial, and government researchers in its first year of availability. MAD7 was recently recognized by the Scientistmagazine as one of […]

Research in space will use Emulate’s Organs-on-Chips technology to understand changes in the intestinal response to bacterial infection BOSTON–Emulate, Inc. announced today that it has received a research grant to use the company’s Intestine-Chip to conduct experiments that will provide insights into the function of the intestinal barrier and its response to bacterial invasion in microgravity. […]

Cambridge, UK: Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today announces that it has entered into an exclusive target discovery partnership with C4X Discovery Holdings plc (AIM: C4XD) (“C4XD”), a pioneering drug discovery company. The partnership aims to validate the novel synthetic lethal oncology […]

VIENNA — Today Lexogen launches a Version 2 (V2) upgrade for the TeloPrime Full-Length cDNA Amplification Kit; an all-in-one protocol for generating 5′ cap-specific full-length cDNA from as little as 1 ng of total RNA. The new TeloPrime V2 Kits provide higher yields and enhanced representation of longer cDNAs than the initial version. Long-read sequencing technologies, […]

Dublin, Ireland – ERS Genomics Limited and Lonza Pharma & Biotech announced today a license agreement to provide Lonza with access to ERS Genomics’ CRISPR/Cas9 genome editing technology patents. Lonza will have the ability to utilize CRISPR/Cas9 in its bioproduction products and services and also for use in induced pluripotent stem cells (iPSC) for research applications. […]

Largest-ever Protein Measurement Study Enhances deCODE’s Efforts in Basic Research, Drug Discovery and Novel Protein-based Diagnostics deCODE genetics, an Amgen subsidiary, and SomaLogic, Inc. today announced a collaboration that brings together SomaLogic’s expertise in human proteins with deCODE’s expertise in human genetics. The collaboration combines deCODE’s rich data sets with SomaLogic’s leading protein measurement capabilities […]